Growth Metrics

Galectin Therapeutics (GALT) Profit After Tax Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 33.04%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 30.60%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -154.28%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.80%
7 Evaxion A 64.16 Bn 64.14 Bn - 16.53%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 47.10%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 24.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.07%
Dec 31, 2025 19.73%
Sep 30, 2025 1.63%
Jun 30, 2025 7.85%
Mar 31, 2025 1.02%
Dec 31, 2024 -18.34%
Sep 30, 2024 -9.61%
Jun 30, 2024 -13.55%
Mar 31, 2024 -21.93%
Dec 31, 2023 -8.38%
Sep 30, 2023 -20.61%
Jun 30, 2023 -14.23%
Mar 31, 2023 -48.00%
Dec 31, 2022 -27.45%
Sep 30, 2022 -45.62%
Jun 30, 2022 -47.46%
Mar 31, 2022 -61.11%
Dec 31, 2021 -33.28%
Sep 30, 2021 -45.75%
Jun 30, 2021 -30.06%
Mar 31, 2021 -14.18%
Dec 31, 2020 -48.83%
Sep 30, 2020 -10.47%
Jun 30, 2020 -10.69%
Mar 31, 2020 10.36%
Dec 31, 2019 -3.82%
Sep 30, 2019 14.95%
Jun 30, 2019 18.41%
Mar 31, 2019 29.58%
Dec 31, 2018 13.24%
Sep 30, 2018 22.39%
Jun 30, 2018 6.13%
Mar 31, 2018 4.09%
Dec 31, 2017 13.89%
Sep 30, 2017 -7.81%
Jun 30, 2017 -9.55%
Mar 31, 2017 1.14%
Dec 31, 2016 -17.93%
Sep 30, 2016 -8.51%
Jun 30, 2016 -29.45%
Mar 31, 2016 -28.52%
Dec 31, 2015 -25.27%
Sep 30, 2015 -29.85%
Jun 30, 2015 -20.40%
Mar 31, 2015 -35.26%
Dec 31, 2014 -3.47%
Sep 30, 2014 -20.16%
Jun 30, 2014 -3.12%
Mar 31, 2014 -28.79%
Dec 31, 2013 -56.66%
Sep 30, 2013 -47.27%
Jun 30, 2013 -15.43%